CICCAGLIONE, ANTONIO FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 648
EU - Europa 576
AS - Asia 210
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.435
Nazione #
US - Stati Uniti d'America 644
IT - Italia 139
CN - Cina 114
IE - Irlanda 101
SE - Svezia 77
UA - Ucraina 70
FR - Francia 65
GB - Regno Unito 48
TR - Turchia 47
DE - Germania 33
IN - India 30
FI - Finlandia 16
PL - Polonia 10
VN - Vietnam 8
RO - Romania 6
BE - Belgio 4
HK - Hong Kong 4
KR - Corea 3
AT - Austria 2
CA - Canada 2
ES - Italia 2
MX - Messico 2
TW - Taiwan 2
EU - Europa 1
ID - Indonesia 1
LU - Lussemburgo 1
NO - Norvegia 1
RU - Federazione Russa 1
SG - Singapore 1
Totale 1.435
Città #
Chandler 135
Jacksonville 103
Dublin 98
Dearborn 73
Princeton 38
Southend 38
Ashburn 36
Nanjing 35
Izmir 32
Wilmington 32
Chieti 19
Cambridge 17
Woodbridge 15
Ann Arbor 14
Beijing 13
Rome 12
Hebei 11
Kraków 10
Dong Ket 8
Los Angeles 8
Nanchang 8
Shenyang 7
Boardman 6
Hangzhou 6
Houston 6
New York 6
Varallo 6
Altamura 5
Hefei 5
Jiaxing 5
Tianjin 5
Bologna 4
Brussels 4
Hong Kong 4
Pescara 4
Seattle 4
Sulmona 4
Washington 4
Düsseldorf 3
Edinburgh 3
Falls Church 3
Frankfurt am Main 3
Jinan 3
Kunming 3
L'aquila 3
Avezzano 2
Camden 2
Campofranco 2
Cepagatti 2
Changchun 2
Chiavari 2
Cori 2
Guadalajara 2
Helsinki 2
Kaohsiung City 2
Mexico 2
Milan 2
Palermo 2
Parabita 2
Redwood City 2
Siena 2
Baotou 1
Castelnuovo Rangone 1
Changsha 1
Chengdu 1
Fairfield 1
Fuzhou 1
Guangzhou 1
Guardiagrele 1
Haikou 1
Irvine 1
Jakarta 1
Kemerovo 1
Kirkland 1
La Canada Flintridge 1
Latina 1
Leawood 1
Luxembourg 1
Morgantown 1
Ningbo 1
Norwalk 1
Orpington 1
Oslo 1
Ottawa 1
Phoenix 1
Redmond 1
Roseto Degli Abruzzi 1
Scandicci 1
Solbiate Olona 1
Tappahannock 1
Teramo 1
Torrevecchia Teatina 1
Turin 1
Vancouver 1
Vienna 1
Villamagna 1
Zhengzhou 1
Totale 929
Nome #
EFFICACY OF TREATMENT WITH PYLERA IN COMBINATION WITH RANITIDINE ON FIRST-LINE INFECTION HELICOBACTER PYLORI: EXPERIENCE OF A SINGLE CENTER 122
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 103
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 98
SYMPTOM PATTERN IN FUNCTIONAL DYSPEPSIA AND GASTROESOPHAGEAL REFLUX DISEASE: ROLE OF H. PYLORI INFECTION 94
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study. 92
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 84
ESOPHAGITIS AND ITS CAUSES: WHO IS "GUILTY" WHEN ACID IS FOUND "NOT GUILTY"? 81
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD) 76
null 76
TYPICAL AND ATYPICAL SYMPTOMS OF GASTRO ESOPHAGEAL REFLUX DISEASE: DOES Helicobacter pylori MATTER? 75
COMBINED VIDEOCAPSULE ENDOSCOPY (VCE) AND LACTULOSE HYDROGEN BREATH TEST (LHBT): A COMPARATIVE STUDY TO ASSESS ORO-CECAL TRANSIT TIME (OCTT). 75
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC) 74
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD). 72
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC). 72
SPONTANEOUS OPENING OF LES IN ACHALASIA: AN UNCOMMON ON-LINE DOCUMENTATION BY HIGH-RESOLUTION MANOMETRY 66
ROLE OF PRUCALOPRIDE (RESOLOR) IN THE SETTING-UP OF PILLCAM COLON-CAPSULE ENDOSCOPY (CCE). EXPERIENCEFROM A SINGLE CENTRE 61
PRUCALOPRIDE ACCELERATES GASTRIC AND SMALL BOWEL TRANSIT TIMES OF VIDEOCAPSULES ENDOSCOPY 58
Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies 56
PRUCALOPRIDE INCREASES BASAL LES TONE IN PATIENTS WITH ESOPHAGEAL MOTILITY DISORDERS 54
Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies. 15
Totale 1.504
Categoria #
all - tutte 4.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201952 0 0 0 0 0 0 0 0 0 2 9 41
2019/2020327 81 14 3 4 38 48 58 22 3 34 22 0
2020/2021114 15 0 19 3 1 24 6 8 3 19 3 13
2021/2022117 2 2 2 23 6 3 4 7 10 5 10 43
2022/2023334 26 51 20 35 28 72 13 23 38 7 16 5
2023/2024165 14 13 10 5 10 54 28 10 0 21 0 0
Totale 1.504